Feng Li

Feng Li


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 January 2024 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
YNYuan Ni
Yuan Ni
MLMaoqing Lu
Maoqing Lu
MLMing Li
Ming Li
XHXixi Hu
Xixi Hu
FLFeng Li
Feng Li
DXDong Xue
Dong Xue
Background: Nonalcoholic steatohepatitis (NASH) is a progressive manifestation of nonalcoholic fatty liver disease (NAFLD) that can lead to fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). Despite the growing knowledge of NASH and HCC, the association between the two conditions remains to be fully explored. Bioinformatics has emerged as a valuable approach for identifying disease-specific feature genes, enabling advancements in disease prediction, prevention, and personalized treatment strategies. Materials and methods: In this study, we utilized CellChat, copy number karyotyping of aneuploid tumors (CopyKAT), consensus Non-negative Matrix factorization (cNMF), Gene set enrichment analysis (GSEA), Gene set variation analysis (GSVA), Monocle, spatial co-localization, single sample gene set enrichment analysis (ssGSEA), Slingshot, and the Scissor algorithm to analyze the cellular and immune landscape of NASH and HCC. Through the Scissor algorithm, we identified three cell types correlating with disease phenotypic features and subsequently developed a novel clinical prediction model using univariate, LASSO, and multifactor Cox regression. Results: Our results revealed that macrophages are a significant pathological factor in the development of NASH and HCC and that the macrophage migration inhibitory factor (MIF) signaling pathway plays a crucial role in cellular crosstalk at the molecular level. We deduced three prognostic genes (YBX1, MED8, and KPNA2), demonstrating a strong diagnostic capability in both NASH and HCC. Conclusion: These findings shed light on the pathological mechanisms shared between NASH and HCC, providing valuable insights for the development of novel clinical strategies.

3 February 2026 in Phytomedicine
Verified
Journal Article
Closed access
DXDong Xue
Dong Xue
XHXixi Hu
Xixi Hu
RLRanchang Li
Ranchang Li
TSTongyu Sun
Tongyu Sun
SQSiying Qian
Siying Qian
BCBiao Cai
Biao Cai

18 February 2025 in Current Microbiology
Verified
Journal Article
Closed access
PDF file
MLMing Li
Ming Li
XHXixi Hu
Xixi Hu
YNYuan Ni
Yuan Ni
TNTiancheng Ni
Tiancheng Ni
FLFeng Li
Feng Li
DXDong Xue
Dong Xue